FDA Approved: OCREVUS — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for OCREVUS (ocrelizumab) filed by Genentech, indicating an update to the product labeling for this multiple sclerosis t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ocrevus (ocrelizumab)

Snippet

SUPPL AP for OCREVUS (OCRELIZUMAB)